Literature DB >> 1276834

Immediate plasma renin response to propranolol: differentiation between essential and renal hypertension.

F Skrabal, W Czaykowska, P Dittrich, H Braunsteiner.   

Abstract

The immediate short-term effect on plasma renin activity of intravenous injection of propranolol was studied in 31 normal subjects and 166 hypertensive patients. In patients with essential hypertension and normal subjects plasma renin activity fell considerably within 15 minutes; the fall was directly proportional to initial plasma renin levels. In contrast, in patients with renal hypertension the fall was much less pronounced or totally absent. These differences in response to propranolol provide, though presently only on a group basis, a biochemical means of differentiating between patients with renal hypertension and those with essential hypertension. The observations also indicate that, unlike normal subjects and patients with essential hypertension, in patients with renal hypertension sympathetic activity plays no part in the control of basal plasma renin levels.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1276834      PMCID: PMC1687447          DOI: 10.1136/bmj.2.6028.144

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  Adrenergic receptor mediation of renin secretion.

Authors:  N Winer; D S Chokshi; M S Yoon; A D Freedman
Journal:  J Clin Endocrinol Metab       Date:  1969-09       Impact factor: 5.958

2.  The effect of chronic adrenergic receptor blockade on plasma renin activity in man.

Authors:  A M Michelakis; R G McAllister
Journal:  J Clin Endocrinol Metab       Date:  1972-02       Impact factor: 5.958

3.  Renal abnormality of essential hypertension.

Authors:  J J Brown; A F Lever; J I Robertson; M A Schalekamp
Journal:  Lancet       Date:  1974-08-10       Impact factor: 79.321

4.  Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess.

Authors:  M Lebel; M A Schalekamp; D G Beevers; J J Brown; D L Davies; R Fraser; D Kremer; A F Lever; J J Morton; J I Robertson; M Tree; A Wilson
Journal:  Lancet       Date:  1974-08-10       Impact factor: 79.321

5.  Radioimmunoassay determination of plasma-renin activity.

Authors:  G W Boyd; A E Fitz; A R Adamson; W S Peart
Journal:  Lancet       Date:  1969-02-01       Impact factor: 79.321

6.  On the mechanism of suppressed plasma-renin activity during beta-adrenergic blockade with propranolol.

Authors:  E L Bravo; R C Tarazi; H P Dustan
Journal:  J Lab Clin Med       Date:  1974-01

7.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

8.  Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.

Authors:  W A Pettinger; H C Mitchell
Journal:  N Engl J Med       Date:  1975-06-05       Impact factor: 91.245

9.  [Different reaction of plasma renin activity after propranolol in essential and renal hypertension].

Authors:  F Skrabal
Journal:  Klin Wochenschr       Date:  1975-07-01

10.  Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?

Authors:  P L Padfield; J J Brown; A F Lever; M A Schalekamp; D G Beevers; D L Davies; J I Robertson; M Tree
Journal:  Lancet       Date:  1975-03-08       Impact factor: 79.321

View more
  3 in total

1.  Beta-adrenoceptor antagonists and respiratory function.

Authors:  V M Oh; C M Kaye; S J Warrington; E A Taylor; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

2.  Relationship between bronchial effects and plasma practolol concentration in man.

Authors:  V M Oh; E A Taylor; J Wadsworth; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

3.  Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension.

Authors:  M A van Baak; T L Kho; H Thijssen; K H Rahn
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.